RPN1 promotes the proliferation and invasion of breast cancer cells by activating the PI3K/AKT/mTOR signaling pathway

被引:0
作者
Wei-juan Shen
Yi Zhang
机构
[1] Changzhou Wujin People’s Hospital (Wujin Hospital Affiliated with Jiangsu University),Department of Breast surgery
[2] The Wujin Clincal college of Xuzhou Medical University,Department of Breast surgery
来源
Discover Oncology | / 15卷
关键词
RPN1; Breast cancer; PI3K/AKT/mTOR; Migration; Invasion;
D O I
暂无
中图分类号
学科分类号
摘要
Ribophorin I (RPN1), a part of an N-oligosaccharyl-transferase complex, plays a vital role in the development of multiple cancers. However, its biological role in breast cancer has not been completely clarified. The RPN1 expression level was measured in breast cancer tissues and breast cancer cell lines (MCF7) using RT-qPCR. After down-regulating RPN1 expression by shRNA, the effects of RPN1 on the proliferation, migration and invasion of MCF7 cells were examined. Mechanistically, we assessed the effect of RPN1 on the PI3K/ AKT/mTOR signaling pathway. We found that RPN1 level was up-regulated in breast cancer tissues and cells compared with adjacent non-tumor tissues or MCF10A cells. RPN1 knockdown induced apoptosis and attenuated the proliferation, migration, and invasion of MCF7 cells. Moreover, RPN1 knockdown lowered the levels of p-PI3K/PI3K, p-AKT/AKT, and p-mTOR/mTOR, which were rescued by 740Y-P, a PI3K activator. 740Y-P also reversed the effects of RPN1 knockdown on apoptosis, proliferation, migration, and invasion in MCF7 cells. Taken together, RPN1 promotes the proliferation, migration, and invasion of breast cancer cells via the PI3K/AKT/mTOR signaling pathway.
引用
收藏
相关论文
共 171 条
[21]  
Lukasiewicz S(2019)C(1)(8)H(1)(7)NO(6) inhibits invasion and migration of human MNNG osteosarcoma cells via the PI3K/AKT signaling pathway Med Sci Monit 21 648-160
[22]  
Czeczelewski M(2021)Proliferation, migration and invasion of triple negative breast cancer cells are suppressed by berbamine via the PI3K/Akt/MDM2/p53 and PI3K/Akt/mTOR signaling pathways Oncol Lett 101 3335-4525
[23]  
Forma A(2023)Tetrandrine inhibits migration and invasion of BGC-823 and MKN-45 cells by regulating PI3K/AKT/mTOR signaling pathway Chem Biol Drug Des 6 1643-undefined
[24]  
Baj J(1987)Human ribophorins I and II: the primary structure and membrane topology of two highly conserved rough endoplasmic reticulum-specific glycoproteins EMBO J 120 283-undefined
[25]  
Sitarz R(2007)Ribophorin I acts as a substrate-specific facilitator of N-glycosylation J Cell Sci 1875 147-undefined
[26]  
Stanislawek A(2021)Altered glycosylation in cancer: a promising target for biomarkers and therapeutics Biochim Biophys Acta Rev Cancer 3 602-undefined
[27]  
Kuechle JB(2023)Altered glycosylation in progression and management of. bladder cancer Molecules 6 4511-undefined
[28]  
McGrath BE(2013)Ribophorin II regulates breast tumor initiation and metastasis through the functional suppression of GSK3beta Sci Rep 14 undefined-undefined
[29]  
Khoury T(2015)Prognostic and therapeutic impact of RPN2-mediated tumor malignancy in non-small-cell lung cancer Oncotarget 40 undefined-undefined
[30]  
Mindell ER(2021)RPN2 predicts poor prognosis and promotes bladder cancer growth and metastasis via the PI3K-Akt pathway Onco Targets Ther 11 undefined-undefined